FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2103444528> ?p ?o ?g. }

• W2103444528 endingPage "63" @default.
• W2103444528 startingPage "2857" @default.
• W2103444528 abstract "Vandetanib, an oral inhibitor of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling, has attracted wide interest in treatment of advanced non-small-cell lung cancer (NSCLC). We aimed to assess its efficacy and safety via a systematic review and meta-analysis.Trials comparing vandetanib-based therapy and non-vandetanib therapy for advanced NSCLC were identified. Endpoints evaluated were progression-free survival (PFS), overall survival (OS), objective tumor response rate (ORR), and toxicity.Seven trials including 4,492 patients were included in the analysis. As compared with placebo, vandetanib yielded a clear benefit for ORR (odds ratio (OR) = 2.04; 95% CI, 1.60-2.61; P <0.001), and a clinically and statistically significant 25% improvement in PFS (hazard ratio (HR) = 0.75; 95% CI, 0.66- 0.85; P < 0.001). However, these benefits did not translate into a significant improvement in OS (HR = 0.95; 95% CI, 0.88-1.04; P = 0.291). Subgroup analyses showed that vandetanib 100mg/d was associated with greater antitumor activity than 300 mg/d when given in combination with chemotherapy. In addition, the pooled results demonstrated no statistically significant difference between vandetanib and single-targeted agents in PFS, ORR or OS. Vandetanib was associated with more frequent adverse events.Vandetanib, as compared with placebo, significantly increases ORR and PFS, but does not improve OS in the treatment of advanced NSCLC. As compared with single-targeted agent, vandetanib does not provide any efficacy advantage. Furthermore grade 3 or greater toxicity proved greater in the vandetanib arm." @default.
• W2103444528 created "2016-06-24" @default.
• W2103444528 creator A5008103342 @default.
• W2103444528 creator A5011266160 @default.
• W2103444528 creator A5013250939 @default.
• W2103444528 creator A5019102566 @default.
• W2103444528 creator A5029498134 @default.
• W2103444528 creator A5031753073 @default.
• W2103444528 creator A5033893468 @default.
• W2103444528 creator A5037968408 @default.
• W2103444528 creator A5045102265 @default.
• W2103444528 creator A5054458099 @default.
• W2103444528 creator A5069907659 @default.
• W2103444528 creator A5070391038 @default.
• W2103444528 date "2011-01-01" @default.
• W2103444528 modified "2023-09-27" @default.
• W2103444528 title "Efficacy and safety of vandetanib, a dual VEGFR and EGFR inhibitor, in advanced non-small-cell lung cancer: a systematic review and meta-analysis." @default.
• W2103444528 cites W1596902544 @default.
• W2103444528 cites W1986215651 @default.
• W2103444528 cites W1996761484 @default.
• W2103444528 cites W1998482951 @default.
• W2103444528 cites W2004350020 @default.
• W2103444528 cites W2033048942 @default.
• W2103444528 cites W2075642745 @default.
• W2103444528 cites W2101995865 @default.
• W2103444528 cites W2102590541 @default.
• W2103444528 cites W2107328434 @default.
• W2103444528 cites W2107666024 @default.
• W2103444528 cites W2110835998 @default.
• W2103444528 cites W2114940128 @default.
• W2103444528 cites W2115078104 @default.
• W2103444528 cites W2118559000 @default.
• W2103444528 cites W2122553809 @default.
• W2103444528 cites W2124464299 @default.
• W2103444528 cites W2125212831 @default.
• W2103444528 cites W2125435699 @default.
• W2103444528 cites W2125916043 @default.
• W2103444528 cites W2126655764 @default.
• W2103444528 cites W2127101185 @default.
• W2103444528 cites W2127809030 @default.
• W2103444528 cites W2132157071 @default.
• W2103444528 cites W2138297714 @default.
• W2103444528 cites W2145835533 @default.
• W2103444528 cites W2147289344 @default.
• W2103444528 cites W2150335765 @default.
• W2103444528 cites W2152755651 @default.
• W2103444528 cites W2162724777 @default.
• W2103444528 cites W2164093802 @default.
• W2103444528 cites W2433114596 @default.
• W2103444528 cites W2537925245 @default.
• W2103444528 cites W71228264 @default.
• W2103444528 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22393954" @default.
• W2103444528 hasPublicationYear "2011" @default.
• W2103444528 type Work @default.
• W2103444528 sameAs 2103444528 @default.
• W2103444528 citedByCount "3" @default.
• W2103444528 countsByYear W21034445282013 @default.
• W2103444528 countsByYear W21034445282016 @default.
• W2103444528 countsByYear W21034445282020 @default.
• W2103444528 crossrefType "journal-article" @default.
• W2103444528 hasAuthorship W2103444528A5008103342 @default.
• W2103444528 hasAuthorship W2103444528A5011266160 @default.
• W2103444528 hasAuthorship W2103444528A5013250939 @default.
• W2103444528 hasAuthorship W2103444528A5019102566 @default.
• W2103444528 hasAuthorship W2103444528A5029498134 @default.
• W2103444528 hasAuthorship W2103444528A5031753073 @default.
• W2103444528 hasAuthorship W2103444528A5033893468 @default.
• W2103444528 hasAuthorship W2103444528A5037968408 @default.
• W2103444528 hasAuthorship W2103444528A5045102265 @default.
• W2103444528 hasAuthorship W2103444528A5054458099 @default.
• W2103444528 hasAuthorship W2103444528A5069907659 @default.
• W2103444528 hasAuthorship W2103444528A5070391038 @default.
• W2103444528 hasConcept C121608353 @default.
• W2103444528 hasConcept C126322002 @default.
• W2103444528 hasConcept C142724271 @default.
• W2103444528 hasConcept C143998085 @default.
• W2103444528 hasConcept C170493617 @default.
• W2103444528 hasConcept C197934379 @default.
• W2103444528 hasConcept C204787440 @default.
• W2103444528 hasConcept C207103383 @default.
• W2103444528 hasConcept C27081682 @default.
• W2103444528 hasConcept C2776256026 @default.
• W2103444528 hasConcept C2777506169 @default.
• W2103444528 hasConcept C2779438470 @default.
• W2103444528 hasConcept C2780333294 @default.
• W2103444528 hasConcept C42362537 @default.
• W2103444528 hasConcept C44249647 @default.
• W2103444528 hasConcept C71924100 @default.
• W2103444528 hasConceptScore W2103444528C121608353 @default.
• W2103444528 hasConceptScore W2103444528C126322002 @default.
• W2103444528 hasConceptScore W2103444528C142724271 @default.
• W2103444528 hasConceptScore W2103444528C143998085 @default.
• W2103444528 hasConceptScore W2103444528C170493617 @default.
• W2103444528 hasConceptScore W2103444528C197934379 @default.
• W2103444528 hasConceptScore W2103444528C204787440 @default.
• W2103444528 hasConceptScore W2103444528C207103383 @default.
• W2103444528 hasConceptScore W2103444528C27081682 @default.
• W2103444528 hasConceptScore W2103444528C2776256026 @default.

• next